Shai Mulinari

31 – 40 of 101

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/25ef8252-f7b7-4359-8fba-030a7414ec7f?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
3
4
5
6
…
11
next »

2022
Mark Content and strength of conflict of interest policies at Scandinavian Medical Schools: a cross sectional study
Fabbri, Alice ; Mulinari, Shai ^LU ; Johansson, Martin ^LU ; Ghaur, Weda ; Khalil, Abdullah Muhammad and Lundh, Andreas (2022) In BMC Medical Education 22.
- Contribution to journal › Article
Mark De unga gör helt rätt när de stämmer staten
Moberg, Christina ; Corvellec, Hervé ^LU ; Lindroth, Anders ^LU ; Isacson, Manuela ^LU ; Nilsson, Linn ^LU ; Nicholas, Kimberly ^LU ; Björck, Svante ^LU ; Lee, Jayeon ^LU ; Gerle, Elisabeth and Caretta, Martina Angela ^LU , et al. (2022) In Aftonbladet
- Contribution to specialist publication or newspaper › Newspaper article
2021
Mark Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: A European policy review
Ozieranski, Piotr ; Martinon, Luc ; Jachiet, Pierre-Alain and Mulinari, Shai ^LU (2021) In BMJ Open 11.
- Contribution to journal › Article
Mark Is there evidence for the racialization of pharmaceutical regulation? : Systematic comparison of new drugs approved over five years in the USA and the EU
Mulinari, Shai ^LU ; Vilhelmsson, Andreas ^LU ; Ozieranski, Piotr and Bredström, Anna (2021) In Social Science and Medicine 280.
- Contribution to journal › Article
Mark Sociologisk forskning om covid-19-pandemin : En introduktion
Mulinari, Shai ^LU ; Soneryd, Linda and Öhman, Susanna (2021) In Sociologisk Forskning 58(1-2). p.5-15
- Contribution to journal › Debate/Note/Editorial
Mark Pharmaceutical industry self-regulation and non-transparency : country and company level analysis of payments to healthcare professionals in seven European countries
Mulinari, Shai ^LU ; Martinon, Luc ; Jachiet, Pierre-Alain and Ozieranski, Piotr (2021) In Health Policy 125(7). p.915-922
- Contribution to journal › Article
Mark Drug company payments to General Practices in England: cross-sectional and social network analysis
Saghy, Eszter ; Mulinari, Shai ^LU and Ozieranski, Piotr (2021) In PLoS ONE 16(12).
- Contribution to journal › Article
Mark Data Transparency and Pharmaceutical Regulation in Europe : Road to Damascus, or Room without a View?
Davis, Courtney ; Mulinari, Shai ^LU and Jefferson, Tom (2021) p.63-94
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark Sweden
Olofsson, Tobias ^LU ; Vilhelmsson, Andreas ^LU ; Hedlund, Maria ^LU ; Knaggård, Åsa ^LU and Mulinari, Shai ^LU (2021)
- Chapter in Book/Report/Conference proceeding › Chapter in report
Mark Failure of responsive regulation? : Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe
Mulinari, Shai ^LU ; Davis, Courtney and Ozieranski, Piotr (2021) In Journal of White Collar and Corporate Crime 2(2). p.69-80
- Contribution to journal › Article

« previous
1
…
3
4
5
6
…
11
next »